India’s ‘Ozempic’ price war: Generic entry slashes costs of drugs by 90 percent
A fierce price war has erupted among Indian pharmaceutical companies after the Semaglutide patent expiry, with generics priced up to…
A fierce price war has erupted among Indian pharmaceutical companies after the Semaglutide patent expiry, with generics priced up to…